We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.5%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.8B
AUM Growth
+$485M
Cap. Flow
-$250M
Cap. Flow %
-2.12%
Top 10 Hldgs %
39.85%
Holding
1,230
New
34
Increased
603
Reduced
253
Closed
43

Sector Composition

Rank Sector Weight
1 Real Estate 73.1%
2 Technology 4.03%
3 Financials 3.16%
4 Industrials 2.98%
5 Healthcare 2.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGIO icon
1001
Agios Pharmaceuticals
AGIO
$2.25B
$12K ﹤0.01%
371
LGND icon
1002
Ligand Pharmaceuticals
LGND
$5.96B
$12K ﹤0.01%
197
PTCT icon
1003
PTC Therapeutics
PTCT
$6.36B
$12K ﹤0.01%
365
XNCR icon
1004
Xencor
XNCR
$1.48B
$12K ﹤0.01%
358
RETA
1005
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$12K ﹤0.01%
153
AZPN
1006
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$12K ﹤0.01%
100
-450
-82% -$54K
DCPH
1007
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$11K ﹤0.01%
312
+72
+30% +$2.13K
ZGNX
1008
DELISTED
Zogenix, Inc.
ZGNX
$11K ﹤0.01%
268
APLS
1009
DELISTED
Apellis Pharmaceuticals
APLS
$10K ﹤0.01%
398
INSM icon
1010
Insmed
INSM
$23B
$10K ﹤0.01%
549
OMAB icon
1011
Grupo Aeroportuario Centro Norte
OMAB
$5.05B
$10K ﹤0.01%
200
-150
-43% -$7.17K
PCRX icon
1012
Pacira BioSciences
PCRX
$1.04B
$10K ﹤0.01%
262
TCDA
1013
DELISTED
Tricida, Inc. Common Stock
TCDA
$10K ﹤0.01%
309
ALDR
1014
DELISTED
Alder Biopharmaceuticals
ALDR
$10K ﹤0.01%
533
+25
+5% +$286
CHRS icon
1015
Coherus Oncology
CHRS
$224M
$9K ﹤0.01%
440
DNLI icon
1016
Denali Therapeutics
DNLI
$3.75B
$9K ﹤0.01%
604
QURE icon
1017
uniQure
QURE
$2.67B
$9K ﹤0.01%
239
SUPN icon
1018
Supernus Pharmaceuticals
SUPN
$2.76B
$9K ﹤0.01%
332
AKCA
1019
DELISTED
Akcea Therapeutics Inc
AKCA
$9K ﹤0.01%
593
+25
+4% +$533
DBC icon
1020
Invesco DB Commodity Index Tracking Fund
DBC
$1.68B
$8K ﹤0.01%
500
LKFT
1021
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$8K ﹤0.01%
54
-6
-10% -$983
IRWD icon
1022
Ironwood Pharmaceuticals
IRWD
$644M
$8K ﹤0.01%
983
OPK icon
1023
Opko Health
OPK
$921M
$8K ﹤0.01%
3,729
RGNX icon
1024
Regenxbio
RGNX
$624M
$8K ﹤0.01%
232
EIDX
1025
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$8K ﹤0.01%
234

Similar funds

Daiwa Securities Group's Q3 2019 Portfolio in Review

As of Q3 2019, Daiwa Securities Group held 1,230 positions worth $11.8B, up 4.3% from $11.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Daiwa Securities Group's Q3 2019 filing shows 34 new, 603 increased, 253 reduced and 43 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 42,579 shares worth $12.6M. The largest sale was Public Storage, an estimated $190M.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, up from 72% a quarter earlier, followed by Technology and Financials.

  • Daiwa Securities Group's largest Q3 2019 buy was State Street SPDR S&P 500 ETF Trust: 42,579 shares worth $12.6M.
  • Daiwa Securities Group added most to Realty Income in Q3 2019, an estimated $211M increase.
  • Daiwa Securities Group's biggest Q3 2019 reduction was Public Storage, cutting an estimated $190M.
  • Daiwa Securities Group fully exited Coupa Software Incorporated in Q3 2019, selling an estimated $4.17M.
  • Daiwa Securities Group's ten largest holdings make up 40% of its $11.8B portfolio in Q3 2019.
  • Daiwa Securities Group opened 34 new positions and closed 43 in Q3 2019.
  • Daiwa Securities Group's portfolio value rose 4.3% quarter-over-quarter to $11.8B.

Based on Daiwa Securities Group's 13F filing for Q3 2019, filed 4 Nov 2019.